BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today announces its revenue for the 1st quarter of 2016. Ludovic Lastennet, CEO of Implanet, says: “The solid growth in the Group’s revenues is a result of the ongoing momentum and […]